"Patience is a Super Power" - "The Money is in the waiting"
Showing posts with label patent portfolio. Show all posts
Showing posts with label patent portfolio. Show all posts

Friday, March 21, 2025

Quantum Computing Leadership: Here is a "Deep Dive" look at IONQ 10 years after it was founded in 2015

 

900 patents in Quantum computing!

IonQ Deep Dive

Company Overview

Founding and Background: IonQ was founded in 2015 as a spin-out from academic research at the University of Maryland and Duke University​

. Its co-founders are Christopher Monroe and Jungsang Kim – both renowned experts in quantum information science. Monroe, a UMD physics professor (now also affiliated with Duke), is a pioneer of trapped-ion quantum computing, having led early experiments at NIST with Nobel laureate David Wineland that demonstrated the first controllable quantum bits and logic gates​. Kim is a professor at Duke University specializing in scalable quantum computing and communication hardware; he collaborated with Monroe on ion-trap architectures through large research initiatives (e.g. IARPA projects) before they commercialized their work​. With seed backing and technology licensed from their universities, Monroe and Kim set out to take trapped-ion quantum computers “out of the lab and into the market”​.

Early Development: IonQ received $2 million in seed funding from New Enterprise Associates (NEA) at its founding in 2015​

. Dr. David Moehring, a former IARPA quantum program manager, joined as the first CEO in 2016 to help translate the founders’ research into a viable product​. By 2017, IonQ raised an additional $20 million in venture funding led by GV (Google Ventures), with participation from NEA and Amazon Web Services (AWS). This financing enabled IonQ to build its first two quantum computers, which at the time achieved the world’s highest accuracy among quantum systems​. In 2018, the company began offering early access to its trapped-ion quantum processors via a cloud API and developed software tools for programming quantum circuits, laying the groundwork for broader cloud deployment​.

Key Milestones: IonQ’s growth has been marked by several significant milestones:

  • 2019 – New Leadership and Series B: In May 2019, former Amazon executive Peter Chapman was appointed CEO to lead commercialization efforts​

    . Later that year, IonQ secured a $55 million funding round led by Samsung’s Catalyst Fund and Mubadala Capital, bringing total funding to $77M​. This round included new investors like Airbus Ventures and Hewlett Packard Enterprise’s Pathfinder, alongside continued support from GV, NEA, and Amazon​. IonQ also partnered with cloud providers: in 2019 it announced integrations to make its quantum hardware available on Microsoft Azure and expanded its presence on AWS, enabling developers worldwide to access IonQ systems via the cloud.

  • 2020 – Technological Advances: IonQ continued to improve its hardware, developing next-generation trapped-ion systems with increasing qubit counts and fidelity. The company added Google Cloud Platform to its roster of cloud partners in 2020, achieving availability on all three major cloud services​

    . It also formed research collaborations with leading institutions and enterprises to explore quantum applications. In mid-2020, strategic investors Lockheed Martin, Robert Bosch Venture Capital (RBVC), and new deep-tech fund Cambium contributed additional funding, extending IonQ’s Series B and bringing total capital raised to $84M​. This infusion coincided with the appointment of prominent advisors (including Nobel laureate David Wineland) to guide IonQ’s R&D​.

  • 2021 – Public Listing: On October 1, 2021, IonQ became the world’s first publicly traded pure-play quantum computing company. It went public via a merger with dMY Technology Group III, a special-purpose acquisition company (SPAC), and began trading on the NYSE under ticker “IONQ”​

    . The transaction provided IonQ with roughly $636 million in gross proceeds to fuel its growth​. Around this time, IonQ had ~60 employees and nominal revenue, but a robust technological roadmap aiming for commercial quantum advantage by the late 2020s​.

  • 2022–2024 – Expansion and Innovation: With public funding, IonQ accelerated development of its quantum systems. It introduced systems like IonQ Aria and IonQ Forte, steadily improving the “algorithmic qubit” count (a metric of effective computational qubits) – by 2024, IonQ’s latest machines boasted 36 algorithmic qubits, a leading performance in the industry​

    . IonQ also expanded geographically, opening a new 65,000 sq ft R&D and manufacturing facility in Bothell, Washington (near Seattle) in early 2024 – billed as the first dedicated quantum computing factory in the U.S.​. Additionally, the company broadened its scope into quantum networking: it acquired quantum communications firms (e.g. Qubitekk) and agreed to purchase a controlling stake in ID Quantique, moves aimed at integrating quantum networking technology with its computers​. These strides, along with industry accolades, underscore IonQ’s position as a leader in trapped-ion quantum computing.

Investment Overview

IonQ’s investor base includes a mix of top-tier venture capital firms, large technology corporations, institutional investors, and notable individual backers. Below is a summary of major investors, the timing/round of their investment, and their strategic role:

Early-Stage and Venture Funding

  1. New Enterprise Associates (NEA)

    • Amount: $2 million
    • Date: 2015 (Seed Round)
  2. GV (Google Ventures)

    • Amount: Part of $20 million
    • Date: 2017 (Series A/B)
  3. Amazon Web Services (AWS)

    • Amount: Part of $20 million
    • Date: 2017 (Series A/B)
  4. Osage University Partners

    • Amount: Undisclosed
    • Date: Pre-2019
  5. ACME Capital

    • Amount: Part of $55 million
    • Date: 2019 (Series B)
  6. Airbus Ventures

    • Amount: Part of $55 million
    • Date: 2019 (Series B)
  7. Hewlett Packard Pathfinder (HPE)

    • Amount: Part of $55 million
    • Date: 2019 (Series B)
  8. Tao Capital Partners

    • Amount: Part of $55 million
    • Date: 2019 (Series B)
  9. Samsung Catalyst Fund

    • Amount: Co-led $55 million
    • Date: 2019 (Series B)
  10. Mubadala Capital

    • Amount: Co-led $55 million
    • Date: 2019 (Series B)
  11. Correlation Ventures

    • Amount: Part of $55 million
    • Date: 2019 (Series B)

Series B Extension (2020)

  1. Lockheed Martin

    • Amount: Undisclosed
    • Date: 2020 (Series B Extension)
  2. Robert Bosch Venture Capital (RBVC)

    • Amount: Undisclosed
    • Date: 2020 (Series B Extension)
  3. Cambium

    • Amount: Undisclosed
    • Date: 2020 (Series B Extension)

SPAC & PIPE (2021)

  1. dMY Technology Group III (SPAC Sponsor)

    • Amount: Part of ~$636 million total raised
    • Date: 2021 (SPAC Merger)
  2. Fidelity

    • Amount: Part of $350 million PIPE
    • Date: 2021
  3. Silver Lake

    • Amount: Part of $350 million PIPE
    • Date: 2021
  4. Hyundai Motor Company

    • Amount: Part of $350 million PIPE
    • Date: 2021
  5. Kia Corporation

    • Amount: Part of $350 million PIPE
    • Date: 2021
  6. Breakthrough Energy Ventures (Bill Gates)

    • Amount: Part of $350 million PIPE
    • Date: 2021
  7. MSD Partners (Michael Dell)

    • Amount: Part of $350 million PIPE
    • Date: 2021
  8. TIME Ventures (Marc Benioff)

    • Amount: Part of $350 million PIPE
    • Date: 2021

Funding Summary: Prior to going public, IonQ raised roughly $84 million in venture funding through 2020​

. The 2021 SPAC merger (including the PIPE) provided an additional $650+ million in gross proceeds​. This strong capitalization has given IonQ one of the largest war-chests in the quantum computing sector, to be deployed on technology development, hiring, and strategic acquisitions. The diversity of IonQ’s investors – spanning top VC firms, cloud and hardware giants (Amazon, Google, Samsung, HPE), industry end-users (automakers), and world-renowned entrepreneurs – reflects a broad belief in IonQ’s approach. Many of these investors also play strategic roles: for example, corporate backers have become early customers or R&D partners, and several venture investors hold board seats or advisory positions to steer IonQ’s growth.

Nvidia Collaboration Potential

Current Partnerships and Projects: As of today, IonQ and NVIDIA have not announced a formal exclusive partnership or joint venture; however, there is clear ongoing collaboration on hybrid quantum-classical computing initiatives. IonQ has actively integrated its quantum hardware with Nvidia’s software and hardware stack in order to accelerate real-world applications. Notably, IonQ has supported NVIDIA’s CUDA-Q platform (Nvidia’s open-source hybrid quantum-classical computing toolkit) since 2023​

. In November 2024, IonQ demonstrated a breakthrough end-to-end workflow that combined an IonQ Forte quantum computer with Nvidia A100 GPUs using CUDA-Q​. This demo, presented at the SC24 supercomputing conference, showed how an IonQ quantum processor could work in tandem with Nvidia GPU-accelerated classical processing to calculate molecular electronic structures (a task relevant to drug discovery and chemistry)​. The integration leveraged IonQ’s quantum hardware alongside Nvidia’s GPU infrastructure both in the cloud and on-premises, highlighting a seamless hybrid solution. IonQ’s team emphasized that this achievement underscored their commitment to developing quantum-accelerated applications for commercial use, made possible by the CUDA-Q integration​.

IonQ’s engagement with Nvidia extends to industry events and cooperative development. In March 2024, NVIDIA invited IonQ to feature in its first-ever “Quantum Day” at the GPU Technology Conference (GTC)

. IonQ’s Executive Chair Peter Chapman joined Nvidia CEO Jensen Huang on stage for a panel discussing the state of quantum computing and its intersection with classical computing​. During GTC, IonQ (along with partners like AWS and Ansys) showcased a hybrid quantum workflow for drug design that utilized Nvidia’s CUDA-Q platform on AWS Braket with GPU-accelerated post-processing​. This live demonstration illustrated the practical synergy between IonQ’s quantum processors and Nvidia’s AI computing capabilities. While these collaborations were presented as technology demonstrations rather than long-term contracts, they signal a deep alignment – IonQ’s hardware was effectively plugged into Nvidia’s compute ecosystem to tackle complex simulations, suggesting that the two companies’ products can complement each other in enterprise solutions.

Potential Partnership Indicators: The close technical integration and public cooperation between IonQ and Nvidia have fueled speculation that a more formal partnership could be on the horizon. Industry observers have taken note that IonQ appears to have an “inside track” with Nvidia’s quantum program. For example, IonQ’s stock surged over 10% in late 2024 after news of its CUDA-Q integration broke, as investors grew excited about the prospect of a deeper Nvidia collaboration​

. Analysts noted that Nvidia’s increasing interest in quantum computing (highlighted by its dedicated Quantum GTC sessions) could translate into partnerships with leading quantum hardware firms, IonQ being a prime candidate​. In fact, Nvidia’s Quantum Day featured all three public quantum hardware companies (IonQ, Rigetti, D-Wave), but IonQ’s strong showing (and its technical results with Nvidia’s platform) set it apart​. There is hope in the tech community that Nvidia might incorporate IonQ’s quantum systems more directly into its offerings – for instance, by jointly developing a hybrid quantum-classical supercomputing service or even through Nvidia making a strategic investment in IonQ. So far, neither company has announced such a deal, and Nvidia’s CEO has sometimes tempered expectations (Jensen Huang commented that useful quantum computers could be 15+ years away, which briefly depressed IonQ’s stock)​. Still, multiple signs point to a growing partnership:

  • Technical Synergy: IonQ’s trapped-ion technology, known for high fidelity, could benefit from Nvidia’s prowess in control electronics, GPU-based error mitigation, and AI algorithms to run on quantum hardware. Both companies are focused on heterogeneous computing (combining different processors) to solve advanced problems. Nvidia’s CUDA-Q (also referred to as QODA in some contexts) is explicitly designed to orchestrate CPUs, GPUs, and QPUs (quantum processing units) together​

    . IonQ was among the first quantum hardware providers to fully integrate with this stack, giving it a head start in hybrid algorithm development.

  • Shared Ecosystem and Investors: IonQ and Nvidia already share common touchpoints in the tech ecosystem. For example, IonQ’s cloud deployments on AWS and Azure mean its systems can work in Nvidia-powered data centers (since AWS/Azure offer Nvidia GPUs for classical computing). IonQ’s investors and partners include several companies that also collaborate with Nvidia. Notably, Hyundai and Kia, key IonQ stakeholders, are deep partners with Nvidia in the autonomous driving and AI space (Nvidia supplies automotive AI chips to both automakers). These overlapping relationships could facilitate a three-way collaboration in areas like optimizing electric vehicle batteries (Hyundai’s project with IonQ) using Nvidia’s AI simulation tools and IonQ’s quantum algorithms. Furthermore, the presence of high-profile investors like Bill Gates (via BEV) and Michael Dell in IonQ’s camp might add connections – Gates has publicly discussed quantum computing’s timeline in contrast to Nvidia’s CEO​

    , and Dell’s own enterprise computing business closely watches developments in hybrid computing. Such networks increase the likelihood of IonQ being on Nvidia’s radar for any quantum-related ventures.

  • Leadership Engagement: The direct involvement of IonQ’s leadership in Nvidia’s events (and vice versa) suggests a strong rapport. IonQ’s Peter Chapman has called for cooperation between the classical computing giants and quantum startups, rather than competition, indicating IonQ’s openness to partnering with companies like Nvidia for mutual benefit​

    . On Nvidia’s side, hosting IonQ at a headline event signals respect for IonQ’s capabilities. Both companies share a vision of hybrid quantum-classical computing as the path forward in the near term – Nvidia’s CTO has spoken about using GPUs to augment quantum computers, which aligns perfectly with IonQ’s approach.

Outlook: In summary, while no definitive partnership agreement has been announced, IonQ is well-positioned to collaborate closely with Nvidia. It has already demonstrated compatibility with Nvidia’s hardware/software, and the two firms are publicly exploring use cases together. If Nvidia decides to pursue a deeper integration of quantum acceleration into its platforms, IonQ’s track record and relationships put it at the front of the line to be an “accelerator” partner – analogous to how Nvidia works with CPU companies or cloud providers. This could take the form of joint research projects, a formal OEM agreement to offer IonQ quantum systems alongside Nvidia supercomputers, or co-developed cloud services blending IonQ QPUs with Nvidia GPUs for AI/quantum applications. Given the strategic value, some have even speculated about a future Nvidia investment in or acquisition of a quantum company like IonQ, though IonQ’s management has indicated they aim to remain independent and grow into an industry pillar themselves​

. What is clear is that IonQ’s and Nvidia’s interests are aligned in advancing hybrid computing – IonQ brings state-of-the-art quantum hardware, and Nvidia brings the leading classical AI hardware – and together they could tackle problems neither could solve alone. For now, IonQ’s “inside track” comes from being an early and active collaborator in Nvidia’s quantum efforts, which positions it strongly if/when the two decide to deepen their partnership. IonQ’s CEO summed it up: rather than viewing each other as rivals, classical and quantum computing companies “have more commonality than most people think”​ – and IonQ’s work with Nvidia so far exemplifies that common vision.

Sources: The information in this report is drawn from up-to-date public sources, including IonQ’s official announcements and filings, reputable news outlets, and industry analyses. Key references have been cited in the text, and they include IonQ’s press releases (for funding and technical milestones), regulatory filings, university reports, and coverage by publications like ZDNet, Yahoo Finance, Barron’s, and others. These citations substantiate the factual statements about IonQ’s history, investors, and collaborations (for example, IonQ’s 2019 funding round details from GlobeNewswire​

, the 2021 SPAC PIPE investor list from ZDNet​, and the IonQ-Nvidia hybrid demonstration from IonQ’s 2024 press release​). This ensures that the deep dive is based on verifiable information and reflects the latest developments regarding IonQ and its potential collaboration with Nvidia.

-------------------------------------------------------------------------------------------------------
Financials:

As of March 2025, IonQ has significantly expanded its patent portfolio and reported notable financial metrics:

Patent Portfolio:

Financial Position:

  • Revenue: For the fiscal year ending December 31, 2024, IonQ reported total revenue of $43.1 million, reflecting a 95% increase compared to the prior year.Barron's

  • Net Loss: The company recorded a net loss of $220 million for the fourth quarter of 2024, widening from a loss of $41.9 million in the same period the previous year.Barron's

  • Cash Reserves: As of December 31, 2024, IonQ's cash and investments totaled $363.8 million, down from $455.9 million at the end of 2023.Barron's

These figures underscore IonQ's commitment to strengthening its intellectual property assets while navigating the financial challenges typical of emerging technology companies.

Did we just witness the first actual building blocks of a future Quantum Internet as IONQ acquires ID Quantique?


Tuesday, March 11, 2025

Nvidia's interest and investment in Recursion Pharmaceuticals (RXRX) in 2025 could be a game changer for this small-cap!

 

 


Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotechnology company that integrates advanced technologies across biology, chemistry, automation, data science, and engineering to decode complex biological systems. Here's an updated overview of the company's financials, partnerships, technological advancements, product pipeline, and other pertinent information:

Financial Overview

  • Cash Position: As of December 31, 2024, Recursion reported cash, cash equivalents, and restricted cash totaling $603.0 million, up from $401.4 million on the same date in 2023.ir.recursion.com

  • Revenue: The company achieved total revenue of $83 million for the fiscal year 2024, reflecting a strong financial performance.tipranks.com

  • Research and Development Expenses: R&D expenses were $74.6 million for Q3 2024, up from $70.0 million in Q3 2023, indicating continued investment in platform expansion and upgrades.globenewswire.com

  • Net Loss: The net loss for Q3 2024 was $95.8 million, compared to $93.0 million in Q3 2023, reflecting ongoing investments in research and development.globenewswire.com

Strategic Partnerships

  • NVIDIA: In July 2023, NVIDIA invested $50 million in Recursion to accelerate the development of AI foundation models for biology and chemistry. This collaboration leverages Recursion's extensive proprietary dataset and NVIDIA's cloud services, including the DGX™ Cloud and BioNeMo platform, to enhance drug discovery capabilities.en.wikipedia.org

  • Roche and Genentech: In December 2021, Recursion entered into a partnership with Roche and its subsidiary Genentech, potentially worth up to $12 billion, to advance therapies in neuroscience and other areas.en.wikipedia.org

  • Bayer: The company has a strategic collaboration with Bayer focusing on oncology research, building upon a previous partnership targeting fibrotic diseases.en.wikipedia.org

  • Exscientia Acquisition: In August 2024, Recursion acquired UK-based biotechnology company Exscientia for $688 million, adding a technology-enabled clinical pipeline and precision chemistry capabilities.globenewswire.com+1en.wikipedia.org+1

Technological Infrastructure

  • Recursion OS: The company's proprietary operating system integrates wet-lab and dry-lab biology experiments, enabling the generation of massive datasets to map and navigate complex biological relationships.sec.gov

  • BioHive-2 Supercomputer: In May 2024, Recursion completed BioHive-2, an NVIDIA-powered AI supercomputer comprising 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs. Ranked #35 in the TOP500 list of the world's most powerful supercomputers, BioHive-2 significantly enhances Recursion's computational capabilities, facilitating more efficient training of large-scale AI models.

Product Pipeline and Clinical Developments

  • REC-994: This experimental drug targets cerebral cavernous malformation (CCM), a rare brain-related condition. In a mid-stage study reported in September 2024, REC-994 demonstrated safety and tolerability. MRI-based data indicated that the highest dose reduced the number of lesions. However, improvements reported by patients or doctors were not observed at the end of the 12-month treatment period. Recursion plans to meet with the U.S. Food and Drug Administration to discuss further clinical studies.Reuters

  • Clinical Trial Outlook: Recursion anticipates seven clinical trial readouts over the next 18 months for its programs and approximately ten readouts collectively over the same period, including those from the Exscientia acquisition.globenewswire.com+1en.wikipedia.org+1

Intellectual Property

  • Patent Portfolio: As of February 2025, Recursion holds a total of 149 patents globally, with 58 granted. Notably, over 78% of these patents remain active. The majority are filed in the United States, followed by Europe and Canada.

Conclusion

Recursion Pharmaceuticals continues to leverage its robust financial position, strategic partnerships, and advanced technological infrastructure to pioneer AI-driven drug discovery and development. The company's expanding patent portfolio and active clinical pipeline underscore its commitment to transforming the pharmaceutical industry through innovative approaches to complex diseases.

Nvidia-backed Recursion's shares fall on mixed data for rare disorder drug
FaviconReuters

Friday, September 13, 2024

Enovix Corp holds over 130 issued patents, covering various aspects of their innovative battery technology.


Enovix Corporation has developed innovative lithium-ion battery technology, particularly focusing on their proprietary 3D Silicon™ Lithium-ion Battery architecture. The company's technology aims to offer higher energy density, improved performance, and faster charging times compared to traditional lithium-ion batteries.

These patents span areas such as battery architecture, manufacturing processes, and material science, which are key to their development of next-generation lithium-ion batteries.



Robustness of Enovix's Patent Portfolio

1. Extensive Patent Filings:

  • Proprietary Technology Protection: Enovix has filed numerous patents to protect its unique battery architecture and manufacturing processes. While I don't have the exact number of patents and applications, the company has emphasized building a strong intellectual property (IP) portfolio as a core part of its business strategy.

  • Global Coverage: The patents are filed not only in the United States but also in other key markets to ensure broad protection of their technology.

2. Key Areas of Patented Innovations:

  • 3D Cell Architecture:

    • Unique Design: Patents cover their innovative 3D cell architecture that increases energy density by stacking electrodes in a three-dimensional configuration.
    • Improved Performance: This design allows for more active material within the same battery volume, enhancing capacity without increasing size.
  • Silicon Anode Technology:

    • High Energy Density: Patents related to the use of silicon in the anode, which offers significantly higher capacity than traditional graphite anodes.
    • Durability Solutions: Innovations addressing the expansion issues of silicon during charging and discharging cycles, improving battery lifespan.
  • Manufacturing Processes:

    • Precision Engineering: Patents on proprietary manufacturing techniques that enable the production of their advanced battery designs at scale.
    • Cost Efficiency: Innovations that reduce production costs, making their technology more competitive in the market.

3. Competitive Edge Provided by Patents:

  • Barrier to Entry:

    • Protection from Competitors: A robust patent portfolio deters competitors from replicating Enovix's technology, preserving their market advantage.
    • Market Exclusivity: Enables Enovix to capitalize on their innovations without immediate competition in identical technologies.
  • Licensing Opportunities:

    • Revenue Streams: Patents allow Enovix to license their technology to other companies, creating additional income.
    • Strategic Partnerships: Intellectual property can be leveraged to form alliances with manufacturers and suppliers.
  • Investor Confidence:

    • Attracting Investment: A strong IP portfolio signals to investors that the company has valuable, protected assets, potentially leading to increased funding.
    • Market Valuation: Patents contribute to the overall valuation of the company, which can positively affect stock performance.

Conclusion

Enovix appears to have a robust portfolio of patents and patent applications, which likely gives it a competitive edge in the advanced battery market. The company's focus on protecting its technological innovations through patents can:

  • Secure Market Position: Prevent competitors from easily copying their technology.
  • Enhance Profitability: Allow for premium pricing and licensing deals.
  • Drive Growth: Support expansion into new markets and applications.

Recommendations for Further Information

To obtain the most current and detailed information about Enovix's patent portfolio:

  • Company's Investor Relations:

  • Patent Databases:

    • Search the United States Patent and Trademark Office (USPTO) database using "Enovix" as the assignee name to find published patents and applications.
    • Use international patent databases like the World Intellectual Property Organization (WIPO) for global filings.
  • Financial Reports:

    • Review Enovix's filings with the Securities and Exchange Commission (SEC), such as Form 10-K or 10-Q, where they typically discuss their intellectual property strategy and portfolio.
  • Analyst Reports:

    • Consult recent analyst coverage for professional assessments of how Enovix's patents impact their market position.

Disclaimer

Please note that my information is based on data available up to October 2023. There may have been new developments regarding Enovix's patent portfolio after that date. Always refer to the most recent sources for the latest information.

We bought Enovix today ($ENVX on Nasdaq) and here are some reasons why!